CVE-2024-1628

CVE-2024-1628 is a high-severity vulnerability with a CVSS 3.x base score of 8.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

OS command injection vulnerabilities in GE HealthCare ultrasound devices

Frequently asked questions

What is CVE-2024-1628?
OS command injection vulnerabilities in GE HealthCare ultrasound devices
How severe is CVE-2024-1628?
CVE-2024-1628 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2024-1628 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (53rd percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2024-1628?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2024-1628 have an EU (EUVD) identifier?
Yes. CVE-2024-1628 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-17368.
When was CVE-2024-1628 published?
CVE-2024-1628 was published on 2024-05-14 and last updated on 2026-06-17.

References

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →